OcuNexus Therapeutics Stock

ocunexus.comHealthcare / BioTech & PharmaFounded: 1900Funding to Date: $144.36MM

Ocunexus Therapeutics is a biotechnology company focused on inflammasome modulation for treatment of Dry Age-related Macular Degeneration and Diabetic Retinopathy.

Register To Buy and Sell Shares

For more details on financing and valuation for OcuNexus Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access OcuNexus Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like OcuNexus Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

David Pool
Chief Financial Officer
Bradford Duft JD
Co-Founder, President & Board Member
Brian Levy
Chief Executive Officer
Anthony Phillips Ph.D
Medical & Pre-Clinical Consultant
Tracey Sunderland
Chief Operating Officer
Colin Green Ph.D
Scientific Co-Founder & Advisor
David Becker Ph.D
Scientific Co-Founder

Board Members

Howard Greene
Geoffrey Brooke MD
GBS Venture Partners
Bradford Duft JD
Inna Eitan
James Blair Ph.D
Domain Associates
James Mervis JD
Mikhail Getman Ph.D
Rajiv Shukla
Frank Spurway

Frequently Asked Questions About OcuNexus Therapeutics’ Stock

Can you buy OcuNexus Therapeutics’ stock?
OcuNexus Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy OcuNexus Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell OcuNexus Therapeutics’ stock?
Yes, you can sell stock of a private company like OcuNexus Therapeutics. Forge can help you sell your OcuNexus Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is OcuNexus Therapeutics’ stock price?
OcuNexus Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access OcuNexus Therapeutics’ private market stock price with Forge Data.
What is OcuNexus Therapeutics’ stock ticker symbol?
OcuNexus Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Updated on: Jun 16, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.